Furthermore, IL-10 treatment prevents muscle insulin resistance by decreasing obesity-associated macrophages and cytokines in muscle from high-fat diet-treated mice. This evidence concerns the gene IL10 and obesity due to melanocortin 4 receptor deficiency.